OraSure Technologies, Inc. (OSUR:NASDAQ) closed at $4.17 on October 26, 2026, up 0.97% on the day. The stock trades 9.0% below its 52-week high of $4.58 and 100.5% above its 52-week low of $2.08. Over the past year, it gained 39.5%. OraSure Technologies, Inc. is part of the Health Care sector (Medical/Dental Instruments).
In 252 trading sessions since October 24, 2025, OSUR closed higher on 119 days (47%). Its best day was February 26, 2026 (+10.00%) and its worst was October 6, 2026 (-8.27%). The stock moved 10% or more in a single session 1 time. It opened at least 5% above the previous day's high 2 times.
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Its principal products include OraQuick ADVANCE HIV-1/2, OraQuick HIV1/2, OraQuick HIV self-test, OraQuick HCV, OraQuick In-Home HIV test, OraQuick Ebola, OraQuick Zika, OraSure QuickFlu rapid flu A&B test, OraSure, Oragene DX, Oragene DNA, Oragene RNA, ORAcollect, OMNIgene DISCOVER, Performagene LIVESTOCK and Oragene ANIMAL, OMNIgene GUT, OMNIgene SPUTUM, PrepIT MAX, OMNIgene VAGINAL, OMNIgene ORAL, PrepIT, Intercept, MICRO-PLATE DOA assays, Intercept i2, homogeneous DOA assays, and professional and over-the-counter cryosurgical systems. In addition, the company offers oral fluid collection devices to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, pharmacogenomics, personalized medicine, microbiome and animal genetics, and academic...
Find more stocks like OSUR with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.